Search

everythinglearnresearchcommunity

for

Search:↓

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Chestnut flower extract may help reduce prostate cancer growth.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Dutasteride may help shrink prostate cancer tumors.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Androgen receptors help prostate cancer cells grow and resist drugs.

Finasteride may help prevent prostate cancer.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Physical activity, height, and smoking affect prostate cancer risk.

Seven new genetic risk areas for prostate cancer were found.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Finasteride's effects on prostate cancer are not clear from this text.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Serum triglyceride levels are not linked to prostate cancer risk.

Male pattern baldness may be linked to prostate cancer risk.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.